1. Exogenous interleukin‐2 can rescue in‐vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation. (18th April 2020) Authors: Shamriz, O.; Simon, A. J.; Lev, A.; Megged, O.; Ledder, O.; Picard, E.; Joseph, L.; Molho-Pessach, V.; Tal, Y.; Millman, P.; Slae, M.; Somech, R.; Toker, O.; Berger, M. Journal: Clinical and experimental immunology Issue: Volume 200:Number 3(2020) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗